Table 4 Overall and disease-free survival analysis of NKG2DLs MICA/B, ULBP1, ULBP2, ULBP3, RAET1E, and RAET1G
From: MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer
| Â | Disease-Free Survival Time | Â | Overall Survival Time | Â | ||
|---|---|---|---|---|---|---|
| Â | Mean | 95% CI | Log-rank P | Mean | 95% CI | Log-rank P |
MICA/B | Â | Â | Â | Â | Â | Â |
 Low (n = 112) | 127 | 112-141 | 0.027 | 146 | 133-158 | 0.181 |
 High (n = 83) | 164 | 150-178 |  | 169 | 155-183 |  |
ULBP1 | Â | Â | Â | Â | Â | Â |
 Low (n = 106) | 125 | 110-140 | 0.009 | 139 | 125-152 | 0.007 |
 High (n = 77) | 163 | 148-178 |  | 177 | 167-188 |  |
ULBP2 | Â | Â | Â | Â | Â | Â |
 Low (n = 93) | 144 | 127-160 | 0.279 | 165 | 152-178 | 0.640 |
 High (n = 91) | 148 | 134-163 |  | 155 | 141-169 |  |
ULBP3 | Â | Â | Â | Â | Â | Â |
 Low (n = 79) | 136 | 121-151 | 0.364 | 147 | 134-160 | 0.707 |
 High (n = 101) | 139 | 122-157 |  | 159 | 144-173 |  |
RAET1E | Â | Â | Â | Â | Â | Â |
 Low (n = 123) | 157 | 144-170 | 0.018 | 163 | 151-175 | 0.935 |
 High (n = 59) | 116 | 96-137 |  | 149 | 135-164 |  |
RAET1G | Â | Â | Â | Â | Â | Â |
 Low (n = 104) | 159 | 146-172 | 0.029 | 166 | 154-179 | 0.234 |
 High (n = 80) | 127 | 108-146 |  | 149 | 132-165 |  |